PRELUDE CAPITAL MANAGEMENT, LLC - STEMLINE THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 98 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 2.58 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$3,000
+50.0%
322
+49.1%
0.00%–
Q3 2019$2,000
+100.0%
216
+254.1%
0.00%–
Q2 2019$1,0000.0%61
-39.0%
0.00%–
Q3 2016$1,000–100–0.00%–
 Download
Other shareholders

There were no reported owners of STEMLINE THERAPEUTICS INC in Q2 2019.

NameSharesValueWeighting ↓
View complete list of STEMLINE THERAPEUTICS INC shareholders